Product Developed Under License and Alliance Agreement with Geron MENLO PARK, Calif. – Geron Corporation (Nasdaq: GERN) today announced that GE Healthcare has launched the first human cellular assay product for use in drug discovery and toxicity screening, developed under a license and alliance agreement between the two companies. This first commercially available product is […]
Berlin, Germany – ifp – Institute for Product Quality, a leading provider of biotechnology-based products and services for a broad range of life science, biotechnology, diagnostic and food safety applications and Romer Labs® , today announced the signing of a cooperation agreement for ifp’s Food Allergen rapid testing products. Under the terms of the agreement, […]
Enabling improved accuracy in drug safety through better toxicology testing Chalfont St.Giles, October 5th, 2010 – GE Healthcare, a unit of General Electric Company (NYSE: GE), announces the availability of human cardiomyocytes, or heart muscle cells, that provide a more readily available and biologically-relevant alternative to current cell models and primary cells used in drug […]
Berlin – At the international Trade Fair BIOTECHNICA 2010 in Hannover, MicroDiscovery will introduce the latest release of its innovative GeneSpotter software. For version 4.0, the innovative program has been completely renewed and will positively surprise long-time customers as well as potential users. It optimizes microarray analysis by its multitude of features, remaining amazingly easy […]
Berlin – By licensing the Cartagenia BENCH software, ATLAS Biolabs GmbH has expanded its services for the evaluation of genetic data obtained by DNA chip analysis. With the aid of this innovative web-based interpretation software it is possible to screen for disease- and family-specific genetic variations and compare them with public data online. It also […]
System Helps Search for Cancer Therapies, Drug Targets SANTA CLARA, Calif. – Agilent Technologies Inc. (NYSE: A) today introduced the SureSelect Kinome Target Enrichment Kit, enabling researchers to focus next-generation sequencing studies on expressed kinases (the kinome). Researchers increasingly are looking at human kinases as a rich, proven source of biomarkers as well as potential […]
Lawrenceville, NJ – CambridgeSoft repurchased all stock held by Edison Ventures. Total Edison proceeds of $40 million represents 11X return on initial investment and 3X follow-on investment. Most of Edison’s $5 million investment was secondary purchases from early shareholders in this highly cash flow positive company. CambridgeSoft is leading supplier of research software for pharmaceutical, […]
• Kilpest India will hold 51% stake, while the remaining 49% will be held by Biotools. • With this agreement, Biotools enters one of the most populated regions, with more than 1,600 million people (SAARC Region), with 9% growth in the last four years. Kilpest, meanwhile, has diversified its activities entering fully into a sector […]
Specialist in high purity reagents for glycobiology and glycoanalysis – AMSBIO – has announced a number of new and unique kits for proteoglycan research. Glycosaminoglycans (GAGs) are polysaccharides consisting of repeated dimers. All but hyaluronic acid (HA) possess sulfate bases, and exist in living organisms in the form of proteoglycans. Sulfated GAGs play important roles […]
SKi Pro X1000 Offers Superior Sensitivity in Both Micro-well Plate and Flow-Cell Formats for Researchers in Biotech/Pharma San Diego, California – Silicon Kinetics Inc., the pioneering life sciences tool company which introduced the world’s first 3D biosensor surface for label-free biomolecular interaction analysis, announced the general availability of SKi Pro™ X1000. This innovative biosensor instrument […]
Pay Invoice
Latest Blogs
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
-
Carterra Introduces Faster SPR
March 27, 2026 7:26 pm
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
